A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia. That’s a potential game changer for the more than 6 million Americans diagnosed each year and the 100,000 who die from the memory-robbing disease annually.

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and similar GLP-1 agonists, but without muscles loss as a potential side-effect. This is the conclusion of a new study by an international team of researchers led from the biotech firm Atrogi AB.

Lizzo revealed on the 'Just Trish' podcast on June 19 that she has tried Ozempic and other GLP-1 drugs — which are medications that have become popular with celebrities due to their appetite-regulating effects — but that she no longer uses them and instead utilizes a 'mind-over-matter' approach.